Lin Zhou

机构：Hubei University of Medicine, Ganzhou People's Hospital, Gannan Medical University, First Affiliated Hospital of Gannan Medical University, Hunan Provincial Maternal and Child Health Hospital, Jiangxi University of Science and Technology, Nanjing University · ORCID：0000-0002-1958-5286

发表论文 64 篇 · 总被引 908 次 · h-index 18

代表论文

Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis (2023 · Stem Cell Research & Therapy · 被引 46)
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori ‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial (2022 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 被引 40)
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study (2023 · Journal of Gastroenterology · 被引 38)
Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer (2022 · Signal Transduction and Targeted Therapy · 被引 29)
Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis (2024 · Biomedicine & Pharmacotherapy · 被引 25)
Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study (2022 · Helicobacter · 被引 19)